Brand Name: COBENFY Generic Name: xanomeline and trospium chloride . COBENFY (xanomeline and trospium chloride) is used to treat schizophrenia in adults.
FDA Approves Drug with New Mechanism of Action for Treatment of Schizophrenia. The U.S. Food and Drug Administration approved Cobenfy (xanomeline and trospium chloride) capsules for oral use for the treatment of schizophrenia in adults. It is the first antipsychotic drug approved to treat schizophrenia that targets cholinergic receptors as opposed to dopamine receptors, which has long been the standard of care.
Brand Name: | COBENFY |
Generic Name: | xanomeline and trospium chloride |
Strength: | Capsules (xanomeline/trospium chloride): 50 mg/20 mg, 100 mg/20 mg, 125 mg/30 mg |
Manufacturer: | Bristol-Myers Squibb |
Approved By: | EMA, USFDA |
Source Details: Patient Information
IPN, New Delhi can facilitate patient to import of “COBENFY (xanomeline and trospium chloride)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for COBENFY (xanomeline and trospium chloride) price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.